Advanced in Leber Hereditary Optic Neuropathy (LHON)

Christophe Verny

CHU D'Angers
Angers, FR 
Advanced in Leber Hereditary Optic Neuropathy (LHON)
CHU D'Angers
Angers, FR 
OverviewLocationsClinical Research

Overview

Christophe Verny practices in Angers, France. Mr. Verny is rated as an Advanced expert by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Huntington Disease, Optic Nerve Atrophy, Mitochondrial Complex 1 Deficiency, and Primary Familial Brain Calcification.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles and participated in 1 clinical trial in the study of Leber Hereditary Optic Neuropathy (LHON).

Gender
Male

Locations

CHU d'Angers
Angers, France
Other Locations
CHU d'Angers
France
Strasbourg, France
78 Rue Du Général Leclerc, Le Kremlin Bicêtre, Rouez, 94270, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Phase: Phase 2
Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Enrollment Status: Completed
Publish Date: February 04, 2025
Evaluation of METAglut1 Diagnostic Test Performances in Patients With a Clinical Suspicion of GLUT1 Deficiency Syndrome
Evaluation of METAglut1 Diagnostic Test Performances in Patients With a Clinical Suspicion of GLUT1 Deficiency Syndrome
Enrollment Status: Completed
Publish Date: December 01, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: July 16, 2021
Intervention Type: Drug
View 3 Less Clinical Trials

89 Total Publications

Camptocormia as a Phenotypic Variant of FSHD in the Elderly: Clinical, Genetic, and Imaging Features.
Camptocormia as a Phenotypic Variant of FSHD in the Elderly: Clinical, Genetic, and Imaging Features.
Journal: European journal of neurology
Published: May 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Verny's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile